These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 21482786)

  • 1. Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells.
    Ong CC; Jubb AM; Haverty PM; Zhou W; Tran V; Truong T; Turley H; O'Brien T; Vucic D; Harris AL; Belvin M; Friedman LS; Blackwood EM; Koeppen H; Hoeflich KP
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7177-82. PubMed ID: 21482786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents.
    Ong CC; Gierke S; Pitt C; Sagolla M; Cheng CK; Zhou W; Jubb AM; Strickland L; Schmidt M; Duron SG; Campbell DA; Zheng W; Dehdashti S; Shen M; Yang N; Behnke ML; Huang W; McKew JC; Chernoff J; Forrest WF; Haverty PM; Chin SF; Rakha EA; Green AR; Ellis IO; Caldas C; O'Brien T; Friedman LS; Koeppen H; Rudolph J; Hoeflich KP
    Breast Cancer Res; 2015 Apr; 17(1):59. PubMed ID: 25902869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockage of PAK1 alleviates the proliferation and invasion of NSCLC cells via inhibiting ERK and AKT signaling activity.
    Song P; Song B; Liu J; Wang X; Nan X; Wang J
    Clin Transl Oncol; 2021 Apr; 23(4):892-901. PubMed ID: 32974862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer.
    Korobeynikov V; Borakove M; Feng Y; Wuest WM; Koval AB; Nikonova AS; Serebriiskii I; Chernoff J; Borges VF; Golemis EA; Shagisultanova E
    Breast Cancer Res Treat; 2019 Sep; 177(2):369-382. PubMed ID: 31254157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting PKCι-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma.
    Ito M; Codony-Servat C; Codony-Servat J; Lligé D; Chaib I; Sun X; Miao J; Sun R; Cai X; Verlicchi A; Okada M; Molina-Vila MA; Karachaliou N; Cao P; Rosell R
    Cell Commun Signal; 2019 Oct; 17(1):137. PubMed ID: 31660987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P21-activated kinase 1 (PAK1) as a therapeutic target in BRAF wild-type melanoma.
    Ong CC; Jubb AM; Jakubiak D; Zhou W; Rudolph J; Haverty PM; Kowanetz M; Yan Y; Tremayne J; Lisle R; Harris AL; Friedman LS; Belvin M; Middleton MR; Blackwood EM; Koeppen H; Hoeflich KP
    J Natl Cancer Inst; 2013 May; 105(9):606-7. PubMed ID: 23535073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of p21-activated kinase 1 inhibition on 11q13-amplified ovarian cancer cells.
    Prudnikova TY; Villamar-Cruz O; Rawat SJ; Cai KQ; Chernoff J
    Oncogene; 2016 Apr; 35(17):2178-85. PubMed ID: 26257058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced PAK1 activity sensitizes FA/BRCA-proficient breast cancer cells to PARP inhibition.
    Villamar Cruz O; Prudnikova TY; Araiza-Olivera D; Perez-Plasencia C; Johnson N; Bernhardy AJ; Slifker M; Renner C; Chernoff J; Arias-Romero LE
    Oncotarget; 2016 Nov; 7(47):76590-76603. PubMed ID: 27740936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting PAK1 with the Small Molecule Drug AK963/40708899 Suppresses Gastric Cancer Cell Proliferation and Invasion by Downregulation of PAK1 Activity and PAK1-Related Signaling Pathways.
    Zhou Y; Zhang J; Wang J; Cheng MS; Zhao DM; Li F
    Anat Rec (Hoboken); 2019 Sep; 302(9):1571-1579. PubMed ID: 30773850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p21-activated kinase 1: PAK'ed with potential.
    Ong CC; Jubb AM; Zhou W; Haverty PM; Harris AL; Belvin M; Friedman LS; Koeppen H; Hoeflich KP
    Oncotarget; 2011 Jun; 2(6):491-6. PubMed ID: 21653999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-cancer effect of novel PAK1 inhibitor via induction of PUMA-mediated cell death and p21-mediated cell cycle arrest.
    Woo TG; Yoon MH; Hong SD; Choi J; Ha NC; Sun H; Park BJ
    Oncotarget; 2017 Apr; 8(14):23690-23701. PubMed ID: 28423593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of PAK1 Inhibits the Proliferation and Invasion of Non-Small Cell Lung Cancer Cells Through the ERK Pathway.
    Wang S; Wang SY; Du F; Han Q; Wang EH; Luo EJ; Liu Y
    Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):602-610. PubMed ID: 31394555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21.
    Wang Y; Gu X; Li W; Zhang Q; Zhang C
    J Dermatol Sci; 2018 Apr; 90(1):60-67. PubMed ID: 29307600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of P21-Activated Kinase 1 (PAK1)/CREB Axis in Squamous Non-Small Cell Lung Carcinoma.
    Chung JH; Kim DH; Kim YS; Son BS; Kim D; Hwang C; Shin D; Noh SG; Han JH; Kim DK; Kim JH; Koo JS; Chung HY; Yoon SH
    Cell Physiol Biochem; 2018; 50(1):304-316. PubMed ID: 30282071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Group I Pak inhibitor Frax-1036 sensitizes 11q13-amplified ovarian cancer cells to the cytotoxic effects of Rottlerin.
    Prudnikova TY; Chernoff J
    Small GTPases; 2017 Oct; 8(4):193-198. PubMed ID: 27427770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-elemene enhances the radiosensitivity of gastric cancer cells by inhibiting Pak1 activation.
    Liu JS; Che XM; Chang S; Qiu GL; He SC; Fan L; Zhao W; Zhang ZL; Wang SF
    World J Gastroenterol; 2015 Sep; 21(34):9945-56. PubMed ID: 26379399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathways: targeting p21-activated kinase 1 signaling in cancer--opportunities, challenges, and limitations.
    Eswaran J; Li DQ; Shah A; Kumar R
    Clin Cancer Res; 2012 Jul; 18(14):3743-9. PubMed ID: 22595609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P21 activated kinase signaling in cancer.
    Rane CK; Minden A
    Semin Cancer Biol; 2019 Feb; 54():40-49. PubMed ID: 29330094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of p-21-activated kinases in cancer progression.
    King H; Nicholas NS; Wells CM
    Int Rev Cell Mol Biol; 2014; 309():347-87. PubMed ID: 24529727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p21-activated kinase 1 activity is required for histone H3 Ser
    Zhang N; Li X; Liu X; Cao Y; Chen D; Liu X; Wang Q; Du J; Weng J; Ma W
    Reprod Fertil Dev; 2017 Jul; 29(7):1287-1296. PubMed ID: 27166635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.